热门资讯> 正文
Plus Therapeutics宣布从CPRIT预付160万美元
2025-07-23 19:41
- Plus Therapeutics (NASDAQ:PSTV) Wednesday said that it has received notice of an advance payment of $1.6 million from the Cancer Prevention and Research Institute of Texas.
- The payment is part of the company’s previously awarded $17.6 million grant.
- "This latest CPRIT disbursement and additional funding expected to be received over the next 12 months of approximately $6 million continues to provide significant non-dilutive financing,” said Andrew Sims, Plus Therapeutics Chief Financial Officer.
More on Plus Therapeutics
- Plus Therapeutics drops 5%, files prospectus for 17M share secondary offering
- Plus Therapeutics receives Nasdaq delinquency notice
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Historical earnings data for Plus Therapeutics
- Financial information for Plus Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
